Statera Biopharma gets go-ahead for next phase of Crohn’s therapy trial
FORT COLLINS — Statera Biopharma Inc. (Nasdaq: STAB) has received approval from the Central Institutional Review Board to move forward […]
Source: BizWest
Related Articles
WORKSPACE INNOVATIONS NCCAR CCIM SCHOLARSHIP!
WORKSPACE INNOVATIONS CCIM NCCAR SCHOLARSHIP GOING ON NOW!! WORKSPACE INNOVATIONS HAS ANNOUNCED THEIR ANNUAL NCCAR CCIM SCHOLARSHIP FOR (2) NCCAR…
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
A new Foothills — again
FORT COLLINS — The new owners who want to revitalize midtown Fort Collins’ half-century-old Foothills mall say they envision “a…
Land-use debate polarizes Fort Collins
FORT COLLINS — Drastically altered changes to Fort Collins’ land-use codes passed by the City Council on Nov. 1, which…
Statera Biopharma faces involuntary bankruptcy petition
FORT COLLINS — Statera Biopharma Inc. (Nasdaq: STAB) was served last month with a petition from its creditors to involuntarily…